Ming-Chih Liu

发表

myelodysplastic syndrome and its stability during disease evolution mutation in patients with SRSF2 The clinical implication of

B. Ko, M. Yao, Chien-Yuan Chen, 2012 .

The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution.

B. Ko, M. Yao, Chien-Yuan Chen, 2012, Blood.

An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan, 2010

Luan-Yin Chang, T. Tsou, Sung-Hsi Wei, 2011, BMC infectious diseases.

AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.

Chieh-Yu Liu, B. Ko, M. Yao, 2009, Blood.

Clinical Trials and Observations

Chieh-Yu Liu, K. Trinkaus, P. Westervelt, 2022 .

leukemia patients with intermediate-risk cytogenetics mutation is an unfavorable prognostic factor in acute myeloid TET2

Chieh-Yu Liu, B. Ko, K. Kuo, 2011 .

Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)

Chieh-Yu Liu, C. Li, M. Yao, 2016, Oncotarget.

Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression

Chieh-Yu Liu, B. Ko, M. Yao, 2014, American journal of hematology.

IPSS‐R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk‐stratify the patients

Chieh-Yu Liu, B. Ko, C. Li, 2014, American journal of hematology.